TIMP1 and colorectal carcinoma: Overall, the prognosis of patients with CRC has improved with important discoveries regarding the ability of CEA, C-reactive protein, serum CD26 and TIMP-1 to assist in CRC diagnosis, in addition to innovative surgical techniques and adjuvant therapy [5–7].